2016-11-15T11:19:32-06:00 2015-12-31 410746749 CLIFTONLARSONALLEN LLP 610 W GERMANTOWN PIKE STE 400 PLYMOUTH MEETING PA 19462 990 2015-01-01 460902111 RTOG FOUNDATION INC RTOG 2157170834 1818 MARKET STREET NO 1720 PHILADELPHIA PA 191033653 WALTER J CURRAN JR CHAIRMAN 2157170834 2016-11-14 1 DAVID JACOBSON P01685411 2156433900 2015 2017-02-10 21:41:12Z WALTER J CURRAN JR 1818 MARKET STREET NO 1720 PHILADELPHIA PA 191033653 11947363 0 X WWW.RTOG.ORG X 2012 PA TO ORGANIZE AND PROVIDE FUNDING FOR CLINICAL COOPERTATIVE GROUP ACTIVITIES AND RESEARCH IN THE FIELD OF ONCOLOGY. 9 9 0 0 0 0 41051 11936635 0 0 0 0 0 10728 41051 11947363 0 0 0 0 0 0 0 0 0 3739 8528340 3739 8528340 37312 3419023 37473 3456496 0 0 37473 3456496 X TO ORGANIZE AND PROVIDE FUNDING FOR CLINICAL COOPERTATIVE GROUP ACTIVITIES AND RESEARCH IN THE FIELD OF ONCOLOGY. 0 0 8377475 RTOG FOUNDATION'S MISSION IS TO 1) IMPROVE THE SURVIVAL OUTCOME AND QUALITY OF LIFE OF ADULTS WITH CANCER THROUGH THE CONDUCT OF HIGH-QUALITY CLINICAL TRIALS 2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH 3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION 4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOG'S MEMBERSHIP IN NRG ONCOLOGY 5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOG'S RESEARCH MISSION 6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOG IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES 7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOG RESEARCH ENTERPRISE. 8377475 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 9 9 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 0 0 0 0 0 PA X THE ORGANIZATION 2157170834 1818 MARKET STREET NO 1720 PHILADELPHIA PA 191033653 X WALTER J CURRAN JR MD CHAIR 1.00 X X 0 0 0 MITCHELL MACHTAY MD PRESIDENT 1.00 X X 0 0 0 SHARON HARTSON STINE SECRETARY-TREASURER 5.00 X X 0 0 0 DEBORAH W BRUNER PHD DIRECTOR 1.00 X 0 0 0 HAK CHOY MD DIRECTOR 1.00 X 0 0 0 JAMES DIGNAM MD DIRECTOR 1.00 X 0 0 0 JEFF MICHALSKI MD DIRECTOR 1.00 X 0 0 0 SETH A ROSENTHAL MD DIRECTOR 1.00 X 0 0 0 MARIA WERNER-WASIK MD DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 0 8681557 3255078 11936635 INDIRECT COST REVENUE 621500 10728 10728 10728 11947363 0 0 10728 126345 3308 123037 2300 2300 131322 131322 1375 1375 41178 40785 393 135724 134583 1141 23673 1054 22619 RESEARCH PROJECTS 8066423 8066423 8528340 8377475 150865 0 27422 3446445 10051 10051 37473 3456496 0 0 0 X 37473 3456496 37473 3456496 37473 3456496 3419023 0 X 0 0 0 X 700500 41051 11936635 12678186 700500 41051 11936635 12678186 511687 12166499 10728 10728 12688914 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION A, LINE 8B NO BOARD COMMITTEES HAVE BEEN FORMED AS OF THIS TIME. FORM 990, PART VI, SECTION B, LINE 11 THE RETURN WILL BE REIVEWED BY THE SECRETARY-TREAUSRER AND APPROVED. THE RETURN WILL BE MADE AVAILABLE FOR ALL DIRECTORS PRIOR TO ITS FILING. FORM 990, PART VI, SECTION B, LINE 12C ORGANIZATION REQUIRES DISCLOSURE AND DOCUMENTATION IN MINUTES OF CONFLICTS AT REGULARLY SCHEDULED BOARD MEETINGS FORM 990, PART VI, SECTION C, LINE 19 INFORMATION IS MADE AVAIALABLE TO THE PUBLIC UPON REQUEST. NRG ONCOLOGY FOUNDATION 1600 JFK BLVD STE 1020 PHILADELPHIA PA 19103 900912747 CANCER RESEARCH PA 501C LINE 7 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0